Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by retiredcfon Aug 29, 2021 2:37pm
288 Views
Post# 33779687

Interesting Earnings Analysis

Interesting Earnings AnalysisEPS of $0.24 beat estimates of $0.04, and revenue increased 41% year-over-year to $26.2M for the quarter. The majority of this revenue growth is attributable to acquisitions, whereas 7% is due to organic growth. The company reported a net profit margin of 24%, marking the highest profit margin since late 2019, and this was largely due to a change in the fair value of warrants. Revenue growth has been solid, debt levels remain low, liquidity is good, and it generates positive cash flows. Shareholders should be happy with these results. 

So said 5iResearch who it should be noted, have never been fans of PHM/PTQ. But they are big believers in net profit margins which might explain this significant change of opinion. GLTA
<< Previous
Bullboard Posts
Next >>